Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Urologia Internationalis · 2024
DOI: 10.1159/000539028 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Maximilian Haack und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, Johannes Gutenberg University Medical Center, Mainz, Germany. Hauptthemen laut MEDLINE: Fluoroquinolones, Cephalosporins, Anti-Bacterial Agents, Antibiotic Prophylaxis. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Despite increasing resistance of enterobacteria against fluoroquinolones (FLU), they are still widely used during transrectal prostate biopsy (TRPB). This study was designed to analyse infectious complications and risk factors between FLU, cephalosporines (CEPH) and selective other antibiotics (O-AB) used during TRPB.
Methods
664 patients were included retrospectively (152 FLU, 452 CEPH and 60 O-AB). Infectious complications were defined as fever >38.0°C, the in-house definition of complicated urinary tract infection (cUTI) (if all applied: fever >38.0°C, leucocytosis >11.000/µL and positive urine dipstick) or postinterventional bacteriuria. Hospitalisation rate, duration and comorbidities were also assessed. χ2 and Fisher’s exact test were used for group comparison. Multivariate regression analysis assessed the association of comorbidities with infectious complications.
Results
FLU and CEPH were indifferent regarding infectious complications, however in the O-AB group significantly more common compared to FLU and CEPH (11.6, 13.3, 25%, p < 0.05). Duration of hospital stay in CEPH was significantly shorter compared to FLU and O-AB (4.1 vs. 6.3 vs. 8.2 days, p < 0.05). Arterial hypertension showed increased association with fever (OR 6.002 (1.178; 30.597) p = 0.031) and cUTI (OR 6.006 (1.207; 29.891) p = 0.029).
Conclusion
Infectious complications were low and indifferent between FLU and CEPH but significantly more frequent in O-AB. Arterial hypertension was significantly associated with postinterventional fever and cUTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, Johannes Gutenberg University Medical Center, Mainz, Germany.
- Interdisciplinary Center for Clinical Trials, Johannes Gutenberg University Medical Center, Mainz, Germany.
- Department of Urology and Pediatric Urology, Faculty of Medicine at Eberhard Karls University, Tübingen, Germany.
Zitieren
APA
Haack, M., Ruckes, C., Dotzauer, R., Thomas, A., Sparwasser, M. P., Fischer, N. D., Frey, L. J., Duwe, G., Haferkamp, A., Tsaur, I., & Brandt, M. P. (2024). Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate Biopsy. Urologia Internationalis. https://doi.org/10.1159/000539028
Vancouver
Haack M, Ruckes C, Dotzauer R, Thomas A, Sparwasser MP, Fischer ND, et al. Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate Biopsy. Urologia Internationalis. 2024. doi:10.1159/000539028
BibTeX
@article{Haack2024,
author = {Haack, Maximilian and Ruckes, Christian and Dotzauer, Robert and Thomas, Anita and Sparwasser, Maximilian P and Fischer, Nikita D and Frey, Lisa J and Duwe, Gregor and Haferkamp, Axel and Tsaur, Igor and Brandt, Maximilian P},
title = {Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate Biopsy},
journal = {Urologia Internationalis},
year = {2024},
doi = {10.1159/000539028}
}
EUVIMED